133 related articles for article (PubMed ID: 37739109)
21. Weight and weight changes in early adulthood and later breast cancer risk.
Rosner B; Eliassen AH; Toriola AT; Chen WY; Hankinson SE; Willett WC; Berkey CS; Colditz GA
Int J Cancer; 2017 May; 140(9):2003-2014. PubMed ID: 28133728
[TBL] [Abstract][Full Text] [Related]
22. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis.
Suzuki R; Orsini N; Saji S; Key TJ; Wolk A
Int J Cancer; 2009 Feb; 124(3):698-712. PubMed ID: 18988226
[TBL] [Abstract][Full Text] [Related]
23. Clinical studies examining the impact of obesity on breast cancer risk and prognosis.
Jain R; Strickler HD; Fine E; Sparano JA
J Mammary Gland Biol Neoplasia; 2013 Dec; 18(3-4):257-66. PubMed ID: 24221746
[TBL] [Abstract][Full Text] [Related]
24. Association between common risk factors and molecular subtypes in breast cancer patients.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
Breast; 2013 Jun; 22(3):344-50. PubMed ID: 22981738
[TBL] [Abstract][Full Text] [Related]
25. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis.
Niraula S; Ocana A; Ennis M; Goodwin PJ
Breast Cancer Res Treat; 2012 Jul; 134(2):769-81. PubMed ID: 22562122
[TBL] [Abstract][Full Text] [Related]
26. Relationship of weight to the promotion of breast cancer after menopause.
de Waard F; Poortman J; Collette BJ
Nutr Cancer; 1981; 2(4):237-40. PubMed ID: 7050920
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues.
Heng YJ; Wang J; Ahearn TU; Brown SB; Zhang X; Ambrosone CB; de Andrade VP; Brufsky AM; Couch FJ; King TA; Modugno F; Vachon CM; DuPre NC; Garcia-Closas M; Troester MA; Hunter DJ; Eliassen AH; Tamimi RM; Hankinson SE; Beck AH
Breast Cancer Res Treat; 2019 Feb; 173(3):667-677. PubMed ID: 30387004
[TBL] [Abstract][Full Text] [Related]
28. Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer.
Tamimi RM; Spiegelman D; Smith-Warner SA; Wang M; Pazaris M; Willett WC; Eliassen AH; Hunter DJ
Am J Epidemiol; 2016 Dec; 184(12):884-893. PubMed ID: 27923781
[TBL] [Abstract][Full Text] [Related]
29. Postmenopausal overweight and breast cancer risk; results from the KARMA cohort.
Klintman M; Rosendahl AH; Randeris B; Eriksson M; Czene K; Hall P; Borgquist S
Breast Cancer Res Treat; 2022 Nov; 196(1):185-196. PubMed ID: 36040641
[TBL] [Abstract][Full Text] [Related]
30. Body fatness and breast cancer risk in women of African ancestry.
Bandera EV; Chandran U; Zirpoli G; Gong Z; McCann SE; Hong CC; Ciupak G; Pawlish K; Ambrosone CB
BMC Cancer; 2013 Oct; 13():475. PubMed ID: 24118876
[TBL] [Abstract][Full Text] [Related]
31. Relationship of breast volume, obesity and central obesity with different prognostic factors of breast cancer.
Lubián López DM; Butrón Hinojo CA; Castillo Lara M; Sánchez-Prieto M; Sánchez-Borrego R; Mendoza Ladrón de Guevara N; González Mesa E
Sci Rep; 2021 Jan; 11(1):1872. PubMed ID: 33479372
[TBL] [Abstract][Full Text] [Related]
32. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study.
Suzuki R; Rylander-Rudqvist T; Ye W; Saji S; Wolk A
Int J Cancer; 2006 Oct; 119(7):1683-9. PubMed ID: 16646051
[TBL] [Abstract][Full Text] [Related]
33. The association between body mass index and immunohistochemical subtypes in breast cancer.
Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
[TBL] [Abstract][Full Text] [Related]
34. Serum amyloid a is associated with obesity and estrogen receptor-negative tumors in postmenopausal women with breast cancer.
Santana AB; Gurgel MS; de Oliveira Montanari JF; Bonini FM; de Barros-Mazon S
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):270-4. PubMed ID: 23300020
[TBL] [Abstract][Full Text] [Related]
35. Obesity and Postmenopausal Hormone Receptor-positive Breast Cancer: Epidemiology and Mechanisms.
Zuo Q; Band S; Kesavadas M; Madak Erdogan Z
Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34519778
[TBL] [Abstract][Full Text] [Related]
36. Circulatory estrogen level protects against breast cancer in obese women.
Suba Z
Recent Pat Anticancer Drug Discov; 2013 May; 8(2):154-67. PubMed ID: 23061769
[TBL] [Abstract][Full Text] [Related]
37. Adult weight change and risk of postmenopausal breast cancer.
Eliassen AH; Colditz GA; Rosner B; Willett WC; Hankinson SE
JAMA; 2006 Jul; 296(2):193-201. PubMed ID: 16835425
[TBL] [Abstract][Full Text] [Related]
38. Obesity and risk of the less commonly diagnosed subtypes of breast cancer.
Stark A; Schultz D; Kapke A; Nadkarni P; Burke M; Linden M; Raju U
Eur J Surg Oncol; 2009 Sep; 35(9):928-35. PubMed ID: 19121564
[TBL] [Abstract][Full Text] [Related]
39. Interactions of hormone replacement therapy, body weight, and bilateral oophorectomy in breast cancer risk.
Cui Y; Deming-Halverson SL; Beeghly-Fadiel A; Lipworth L; Shrubsole MJ; Fair AM; Shu XO; Zheng W
Clin Cancer Res; 2014 Mar; 20(5):1169-78. PubMed ID: 24423614
[TBL] [Abstract][Full Text] [Related]
40. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
